Patent · US Active

Inhibitors of RNA helicase DHX9 and uses thereof

US12162867B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

ACCENT THERAPEUTICS, INC. · US

Inventors

Matthew H. Daniels · Somerville, US
Kenneth W. Duncan · Westwood, US
Brian Andrew Sparling · Melrose, US
Andrew Tasker · Simi Valley, US
Gavin Alistair Whitlock · Sandwich, GB

Key dates

Filing date	Mar 28, 2024
Grant date	Dec 10, 2024
Priority date	—
Expiry date	Apr 19, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compounds of the Formula (IIB): or pharmaceutically acceptable salts thereof, which are useful for the inhibition of DHX9 and in the treatment of a variety of DHX9 mediated conditions or diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.